415 related articles for article (PubMed ID: 14687448)
1. Chronic venous insufficiency: the effects of health-care reforms on the cost of treatment and hospitalisation--an Italian perspective.
Allegra C
Curr Med Res Opin; 2003; 19(8):761-9. PubMed ID: 14687448
[TBL] [Abstract][Full Text] [Related]
2. [The clinical and pharmaco-economic aspects of chronic venous insufficiency of the lower limbs].
Stoĭko IuM; Ermakov NA
Angiol Sosud Khir; 2004; 10(4):63-7. PubMed ID: 15627138
[TBL] [Abstract][Full Text] [Related]
3. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
4. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
Wolfenstetter SB
Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
[TBL] [Abstract][Full Text] [Related]
5. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.
Bruno G; Picariello R; Petrelli A; Panero F; Costa G; Cavallo-Perin P; Demaria M; Gnavi R
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):684-90. PubMed ID: 21907553
[TBL] [Abstract][Full Text] [Related]
6. Effects of elastic stocking on quality of life of patients with chronic venous insufficiency. An Italian pilot study on Triveneto Region.
Andreozzi GM; Cordova R; Scomparin MA; Martini R; D'Eri A; Andreozzi F;
Int Angiol; 2005 Dec; 24(4):325-9. PubMed ID: 16355088
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
Andreozzi GM
Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
9. [Management of venous leg ulcer by French physicians, diversity and related costs: a prospective medicoeconomic observational study].
Lévy E; Lévy P
J Mal Vasc; 2001 Feb; 26(1):39-44. PubMed ID: 11240528
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors and hospital discharge rates for gastrointestinal events in Italy: a national ecological study.
Russo P; Brutti C
Clin Ther; 2007 Apr; 29(4):751-8. PubMed ID: 17617299
[TBL] [Abstract][Full Text] [Related]
11. [Dermatology day-care: between official rules and reality].
Ingen-Housz-Oro S; Durand-Zaleski I; Cosnes A; Valeyrie-Allanore L; Moreno JC; Chosidow O; Wolkenstein P
Ann Dermatol Venereol; 2012 Nov; 139(11):701-9. PubMed ID: 23199765
[TBL] [Abstract][Full Text] [Related]
12. The cost of treating type 2 diabetes (CODEIRE).
Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
[TBL] [Abstract][Full Text] [Related]
13. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in chronic venous insufficiency. An Italian pilot study of the Triveneto Region.
Andreozzi GM; Cordova RM; Scomparin A; Martini R; D'Eri A; Andreozzi F;
Int Angiol; 2005 Sep; 24(3):272-7. PubMed ID: 16158038
[TBL] [Abstract][Full Text] [Related]
15. Direct and indirect costs of asthma in Canada, 1990.
Krahn MD; Berka C; Langlois P; Detsky AS
CMAJ; 1996 Mar; 154(6):821-31. PubMed ID: 8634960
[TBL] [Abstract][Full Text] [Related]
16. Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.
Marchetti M; Caruggi M; Colombo G
Clin Ther; 2004 Sep; 26(9):1546-61. PubMed ID: 15531017
[TBL] [Abstract][Full Text] [Related]
17. [Socioeconomic relevance of acute exacerbations of chronic bronchitis in the Federal Republic of Germany. A prospective cost of illness study].
Rychlik R; Pfeil T; Daniel D; Pfeil B; Mast O; Thate-Waschke I; Lorenz J
Dtsch Med Wochenschr; 2001 Mar; 126(13):353-9. PubMed ID: 11332229
[TBL] [Abstract][Full Text] [Related]
18. Healthcare usage and economic impact of non-treated obesity in Italy: findings from a retrospective administrative and clinical database analysis.
Colao A; Lucchese M; D'Adamo M; Savastano S; Facchiano E; Veronesi C; Blini V; Degli Esposti L; Sbraccia P
BMJ Open; 2017 Feb; 7(2):e013899. PubMed ID: 28237961
[TBL] [Abstract][Full Text] [Related]
19. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
20. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
